Other OTC Pharmaceuticals - Eastern Africa

Eastern Africa

Highlights

In Eastern Africa, the revenue generated in the Other OTC Pharmaceuticals market amounted to US$205.40m in 2024.
It is projected that this market will experience an annual growth rate of 1.90% (CAGR 2024-2029).
When compared to other countries worldwide, the United States leads in revenue generation, reaching US$7.17bn in 2024.
In terms of per capita figures, in 2024, each person in Eastern Africa generated revenues of US$0.45.
The Other OTC Pharmaceuticals market in Eastern Africa is experiencing a growing demand for traditional herbal remedies.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other OTC Pharmaceuticals market in Eastern Africa is experiencing steady growth and development, driven by various factors such as changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors.Customer preferences in the Eastern Africa region are shifting towards self-medication and over-the-counter (OTC) pharmaceutical products. This is primarily due to the convenience and accessibility of these products, as well as the increasing awareness and knowledge of consumers regarding self-care and minor health issues. Customers are increasingly seeking quick and effective remedies for common ailments such as cold and flu, allergies, pain relief, and digestive problems.Trends in the market indicate a growing demand for natural and herbal OTC pharmaceutical products in Eastern Africa. This can be attributed to the region's rich biodiversity and traditional medicine practices. Consumers are increasingly opting for natural remedies and traditional herbal medicines, driven by the perception that they are safer, more sustainable, and have fewer side effects compared to synthetic drugs. This trend is also influenced by the global shift towards natural and organic products.Local special circumstances in Eastern Africa, such as a large rural population and limited access to healthcare facilities, contribute to the growth of the Other OTC Pharmaceuticals market. In many remote areas, people rely heavily on OTC pharmaceutical products for self-care and treatment of common ailments, as they may not have easy access to healthcare professionals or prescription medications. Additionally, the affordability of OTC products compared to prescription drugs makes them a preferred choice for many consumers.Underlying macroeconomic factors in Eastern Africa, such as population growth, urbanization, and increasing disposable incomes, are driving the growth of the Other OTC Pharmaceuticals market. The region has a rapidly growing population, which translates into a larger consumer base for OTC products. Urbanization is also contributing to the market growth, as urban dwellers have higher purchasing power and are more likely to seek self-care solutions. Rising disposable incomes enable consumers to afford OTC pharmaceutical products and invest in their health and well-being.In conclusion, the Other OTC Pharmaceuticals market in Eastern Africa is witnessing growth and development due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The shift towards self-medication and natural remedies, coupled with the region's unique healthcare landscape and favorable economic conditions, are driving the demand for OTC pharmaceutical products in Eastern Africa.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.